-
Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer
30 Jan 2023 09:43 GMT
… IIIA non-small cell lung cancer. Unfortunately, many of … with non-small cell lung cancer following surgery and adjuvant … with non-small cell lung cancer.”
"With this approval … with carboplatin and either paclitaxel or paclitaxel protein-bound for …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:12 GMT
… (ETOP).
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … and either paclitaxel or paclitaxel protein-bound … KEYTRUDA and chemotherapy (paclitaxel, paclitaxel protein-bound, or …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:06 GMT
… (ETOP).
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … and either paclitaxel or paclitaxel protein-bound … KEYTRUDA and chemotherapy (paclitaxel, paclitaxel protein-bound, or …
-
10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling
20 Jan 2023 07:17 GMT
… 100 µmol) group, paclitaxel group, paclitaxel and 10-G (50 … 10-G and paclitaxel significantly increased apoptotic … al. Astragaloside IV enhances taxol chemosensitivity of breast cancer … lung cancer cells and potentiate the effects of hydroxyurea and paclitaxel …
-
Compass Therapeutics Announces that the Phase 2 Data of CTX-009 in Combination with Paclitaxel in Patients with Biliary Tract Cancers (BTC) will be Presented at the ASCO GI Cancers Symposium on January 20, 2023
19 Jan 2023 22:00 GMT
… -009 in combination with paclitaxel in patients with biliary … -009 in combination with paclitaxel remain consistent with previous … 009 in combination with paclitaxel or paclitaxel alone in a 2 … pancreatic and non-small cell lung cancer. Partial responses to CTX- …
-
According to CMi Global Paclitaxel Injection Market Size, Forecast, Analysis & Share Surpass US$ 11.4 Billion By 2030
19 Jan 2023 08:41 GMT
… After being chemically synthesized, paclitaxel injection is a gelatinous … period mentioned above.
Paclitaxel Injection Market: Growth … /report/paclitaxel-injection-market/
… Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Others
By End …
-
Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery
13 Jan 2023 12:50 GMT
… , Non-small cell lung cancer; Pm-Pac, Polymeric micellar paclitaxel; Pm, Polymeric micellar … chemotherapy for the treatment of lung cancers: challenges and opportunities. Acta Pharmacol … BA, Bement W. How Taxol/paclitaxel kills cancer cells. Mol Biol …
-
The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immunotherapy
16 Dec 2022 05:17 GMT
… (atezolizumab, carboplatin, and paclitaxel) or BCP (bevacizumab, … of KRAS-mutant lung cancers exhibit different sensitivity … advanced non–small cell lung cancer (NSCLC) harboring KRASG12C … patients with advanced lung cancer and oncogenic driver alterations …
-
Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy
05 Dec 2022 09:10 GMT
… in lung tumor– … lung cancer combination therapy.Keywords: lung cancer, prodrug, etoposide, cisplatin, nanostructured lipid carriers
Introduction
Lung cancer … lung cancer: cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel …
-
Qilu Pharmaceutical Releases Latest Results of QL1706 plus Chemotherapy +/- Bevacizumab for the Treatment of Non-Small Cell Lung Cancer in the Phase II Study at ESMO Asia Congress 2022
02 Dec 2022 23:12 GMT
… treatment of non-small cell lung cancer (NSCLC) were released on 2 … mg/kg) plus chemotherapy (paclitaxel plus carboplatin or pemetrexed plus … -treatment-of-non-small-cell-lung-cancer-in-the-phase-ii-study …
About
© 1995-2023